These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8970947)
1. Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity. Taddeo B; Carlini F; Verani P; Engelman A J Virol; 1996 Dec; 70(12):8277-84. PubMed ID: 8970947 [TBL] [Abstract][Full Text] [Related]
2. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Jenkins TM; Hickman AB; Dyda F; Ghirlando R; Davies DR; Craigie R Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6057-61. PubMed ID: 7597080 [TBL] [Abstract][Full Text] [Related]
3. Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages. Lu R; Nakajima N; Hofmann W; Benkirane M; Jeang KT; Sodroski J; Engelman A J Virol; 2004 Jan; 78(2):658-68. PubMed ID: 14694097 [TBL] [Abstract][Full Text] [Related]
4. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. Engelman A; Liu Y; Chen H; Farzan M; Dyda F J Virol; 1997 May; 71(5):3507-14. PubMed ID: 9094622 [TBL] [Abstract][Full Text] [Related]
5. Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein. Priet S; Navarro JM; Quérat G; Sire J J Biol Chem; 2003 Jun; 278(23):20724-30. PubMed ID: 12670953 [TBL] [Abstract][Full Text] [Related]
6. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae. Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788 [TBL] [Abstract][Full Text] [Related]
7. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus. Li X; Koh Y; Engelman A J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243 [TBL] [Abstract][Full Text] [Related]
8. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. Zhu K; Dobard C; Chow SA J Virol; 2004 May; 78(10):5045-55. PubMed ID: 15113886 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines. Nakajima N; Lu R; Engelman A J Virol; 2001 Sep; 75(17):7944-55. PubMed ID: 11483739 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human immunodeficiency virus type 1 integrase mutants expressed in Escherichia coli. Oh JW; Oh YT; Kim DJ; Shin CG Mol Cells; 1997 Oct; 7(5):688-93. PubMed ID: 9387159 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. Gao K; Butler SL; Bushman F EMBO J; 2001 Jul; 20(13):3565-76. PubMed ID: 11432843 [TBL] [Abstract][Full Text] [Related]
12. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. Lu R; Limón A; Ghory HZ; Engelman A J Virol; 2005 Feb; 79(4):2493-505. PubMed ID: 15681450 [TBL] [Abstract][Full Text] [Related]
13. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. Taddeo B; Haseltine WA; Farnet CM J Virol; 1994 Dec; 68(12):8401-5. PubMed ID: 7966634 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase. Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724 [TBL] [Abstract][Full Text] [Related]
15. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions. Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823 [TBL] [Abstract][Full Text] [Related]
16. Complementation of integrase function in HIV-1 virions. Fletcher TM; Soares MA; McPhearson S; Hui H; Wiskerchen M; Muesing MA; Shaw GM; Leavitt AD; Boeke JD; Hahn BH EMBO J; 1997 Aug; 16(16):5123-38. PubMed ID: 9305653 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitination of non-lysine residues in the retroviral integrase. Wang Z; Hou X; Wang Y; Xu A; Cao W; Liao M; Zhang R; Tang J Biochem Biophys Res Commun; 2017 Dec; 494(1-2):57-62. PubMed ID: 29054407 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration. Chen H; Engelman A J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731 [TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors. Dicker IB; Terry B; Lin Z; Li Z; Bollini S; Samanta HK; Gali V; Walker MA; Krystal MR J Biol Chem; 2008 Aug; 283(35):23599-609. PubMed ID: 18577511 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. Masuda T; Planelles V; Krogstad P; Chen IS J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]